Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies
Aims—To establish a robust method of extracting DNA from paraffin wax embedded bone marrow trephine (PBMT) biopsies for the amplification of relatively long polymerase chain reaction (PCR) products. Method—Xylene and ethanol were used to remove paraffin wax from eight formalin fixed, EDTA decalcifie...
Saved in:
Published in: | Molecular pathology Vol. 53; no. 1; pp. 19 - 23 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
BMJ Publishing Group Ltd and Association of Clinical Pathologists
01-02-2000
BMJ British Medical Journal Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims—To establish a robust method of extracting DNA from paraffin wax embedded bone marrow trephine (PBMT) biopsies for the amplification of relatively long polymerase chain reaction (PCR) products. Method—Xylene and ethanol were used to remove paraffin wax from eight formalin fixed, EDTA decalcified PBMT biopsies and DNA extraction was performed using a Qiagen QIAamp tissue kit. The DNA samples were amplified using nine different PCR primers sets, including those used to detect chromosomal translocations t(11;14) and t(14;18), and clonal B cell populations. A t(11;14) PCR product of approximately 600 base pairs (bp) was sequenced using dye terminator cycle sequencing. Results—All eight DNA samples extracted from PBMT biopsies were amplified successfully to generate DNA fragments up to 643 bp in length. Chromosomal translocations and immunoglobulin gene rearrangements were detected by PCR in some of the samples. Sequencing of the t(11;14) PCR product demonstrated the presence of chimaeric sequences, which included both bcl-1 and immunoglobulin heavy chain (IgH) gene sequences, consistent with the presence of this translocation. Conclusions—This method enables PCR analyses of PBMT biopsies that were not previously possible, offering the prospect of improved accuracy of diagnosis and the monitoring of patients with bone marrow disease. |
---|---|
Bibliography: | istex:6B6460DB87934BC3E3931AB928B74F91E1C1AF73 PMID:10884917 local:0530019 Mrs Wickham, Molecular Genetics Laboratory, Old Pathology Building , Royal Devon and Exeter NHS Healthcare Trust, Barrack Road, Exeter EX2 5DW, Devon, UK email: c.l.wickham@exeter.ac.uk ark:/67375/NVC-JBNP547N-S href:molpath-53-19.pdf ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1366-8714 1472-4154 |
DOI: | 10.1136/mp.53.1.19 |